Intellia Therapeutics Announces New Positive Clinical Data
Extended Phase 1 data reinforce the potential of NTLA-2002 to be a functional cure for people living with hereditary angioedema (HAE)Across all patients...
Source: globenewswire.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Extended Phase. Real-time updates on events, politics, business and more.